Artificial Intelligence and Machine Learning (AI/ML) for Biological and Other Products Regulated by CBER
Use of Artificial Intelligence and Machine Learning (AI/ML) has rapidly become an important component of everyday life. This includes using AI/ML in the development of Medical Products, including Biologics. This page provides an overview of CBER’s activity in AI/ML.
Recommend0 recommendationsPublished in US National Health Agency Sources